Real-time enrollment status for this anca-associated vasculitis clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 3:43 PM UTC
| NCT Number | NCT06868290 |
| Recruiting Status | Recruiting |
| Condition | ANCA-associated vasculitis |
| Phase | PHASE2 |
| Target Enrollment | 126 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | May 20, 2026 (May 20, 2026) |
As of July 17, 2026: Clinical trial NCT06868290 is currently recruiting participants. This phase2 study for anca-associated vasculitis is actively seeking new participants at 11 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06868290 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06868290 was last updated May 20, 2026 (May 20, 2026). HelloStudys verifies this status automatically.